Nurse Practitioner · Boston, MA
NPI
1093260093
Since 2016
Specialty
Nurse Practitioner
Code 363L00000X
Group practices
0
Medicare group memberships
Hospitals
1
Hospital affiliations
800 Washington St
Boston, MA, 02111
Phone (508) 733-0973
Medicare paid, 2024
$21K
288 services
Medicare patients, 2024
71
Average age 75
Drug cost, 2024
$5.7M
1,126 prescriptions
Company payments, 2025
$15K
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Teresa Fogaren was code 99215 (office e&m - established), 152 times for 51 patients. In total Teresa Fogaren billed 288 services in 5 codes, and Medicare paid $21K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-08-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 152 | 51 | $98.17 | $15K |
| 99214 Office E&M - Established | Facility | 85 | 44 | $63.00 | $5,355 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 42 | 22 | $11.67 | $490 |
By year: 2022 $18K for 245 services; 2023 $15K for 227 services; 2024 $21K for 288 services.
Medicare prescription drug claims, 2024
In 2024, the drug Teresa Fogaren prescribed most often to Medicare patients was Acyclovir, with 141 prescriptions and refills. In total Teresa Fogaren wrote 1,126 Medicare prescriptions that cost $5.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Acyclovir Generic | 141 | 317 | 40 | $2,534 |
| Venclexta Venetoclax | 98 | 98 | 11 | $1.5M |
| Revlimid Lenalidomide | 88 | 88 | 14 | $1.4M |
| Dexamethasone Generic | 65 | 90 | 15 | $623 |
| Ninlaro Ixazomib Citrate | 62 | 62 | 11 | $784K |
| Gabapentin Generic | 44 | 76 | Under 11 | $775 |
| Oxycontin Oxycodone Hcl | 39 | 39 | Under 11 | $33K |
| Pomalyst Pomalidomide | 35 | 35 | Under 11 | $694K |
| Oxycodone Hcl Generic | 32 | 32 | Under 11 | $347 |
| Vyndamax Tafamidis | 32 | 32 | Under 11 | $726K |
| Lorazepam Generic | 29 | 29 | Under 11 | $83.54 |
| Atorvastatin Calcium Generic | 28 | 70 | Under 11 | $341 |
| Omeprazole Generic | 27 | 65 | Under 11 | $444 |
| Eliquis Apixaban | 26 | 52 | Under 11 | $29K |
| Torsemide Generic | 24 | 46 | Under 11 | $575 |
Brand drugs: - claims; generic drugs: 680 claims; opioid claims: 90.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Teresa Fogaren $15K ($15K in general payments such as food, travel and fees) from 8 companies. The largest payer was Janssen Biotech, Inc. with $15K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.